CompletedPhase 3NCT01035190
Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia
Studying Bronchopulmonary dysplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Children's Hospital Tuebingen
- Principal Investigator
- Prof. Dr. med. Dirk Bassler, MSc, MDUniversity Children's Hospital Tuebingen / University Hospital Zurich, Department of Neonatology
- Intervention
- Budesonide(drug)
- Enrollment
- 863 enrolled
- Eligibility
- All sexes
- Timeline
- 2010 – 2016
Study locations (30)
- AZ Sint-Jan Brugge Oostende AV, Department of Neontalogy, Bruges, Belgium
- CHU St-Pierre, UMC St-Pieter, Brussels, Belgium
- HUDERF, Department of Neonatology, Brussels, Belgium
- CHU Tivoli, Department of Neonatology, La Louvière, Belgium
- University Hospital Brno, Department of Neonatology, Brno, Czechia
- University Hospital Ostrava, Department of Neonatology, Ostrava, Czechia
- University Hospital Plzen, Department of Neonatology, Pilsen, Czechia
- Charles University, General Faculty Hospital and 1st Faculty of Medicine, Department of Obstetrics and Gynecology, Prague, Czechia
- University Hospital Motol Prague 5, Department of Neonatology, Prague, Czechia
- University Hospital of Tomas Bati, Department of Neonatology, Zlín, Czechia
- Helsinki University Central Hospital,Hospital for Children and Adolescents, NICU, Helsinki, Finland
- University Hospital Kuopio, NICU, Kuopio, Finland
- Oulu University Hospital, Oulu, Finland
- Tampere University Hospita, NICU, Tampere, Finland
- Tartu University Children's Clinic, Paediatric Intensive Care Unit, Tartu, Finland
- +15 more locations on ClinicalTrials.gov
Collaborators
European Union
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01035190 on ClinicalTrials.govOther trials for Bronchopulmonary dysplasia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06373289Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm InfantsUniversity of Alabama at Birmingham
- RECRUITINGPHASE2NCT07561125Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and BelowInternational Peace Maternity and Child Health Hospital
- RECRUITINGNCT07109791National Surveillance and Prevention of Neonatal VAPUniversity of Alberta
- RECRUITINGPHASE2NCT06915441Lipid Infusions to Optimize Nutrition TrialThe University of Texas Health Science Center, Houston
- RECRUITINGPHASE1, PHASE2NCT07101640PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary DysplasiaDuke University
- RECRUITINGNCT07273643Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and MortalityUniversity Hospital, Montpellier
- RECRUITINGEARLY PHASE1NCT07120971Metformin for Premature Infants With Bronchopulmonary DysplasiaMedical College of Wisconsin
- RECRUITINGNCT07134387Long-Term Burden of BPD and Health-Related Quality of Life (BronQ Family)Global Foundation for the Care of Newborn Infants